Insulin Therapy News

• Sanofi to Cut US Price of Its Most-Prescribed Insulin by 78% Sanofi said on Thursday it will cut US list prices for its most-prescribed insulin product, Lantus, by 78% starting next year after similar moves by rivals Novo Nordisk and Eli Lilly.
  Reuters Health Information, March 16, 2023
• Artificial Pancreas 'Superior' in Young Kids With Type 1 Diabetes A hybrid closed-loop automated insulin delivery system benefitted young children with type 1 diabetes aged 2-6 years compared to nonautomated insulin delivery, with mostly virtual care.
  Medscape Medical News, March 15, 2023
• Novo Nordisk to Slash US Insulin Prices, Following Move by Eli Lilly Novo Nordisk said on Tuesday it would cut U.S. list prices for several insulin products by up to 75% next year, joining rival Eli Lilly and Co as political pressure mounts to make these life-sustaining diabetes treatments more affordable.
  Reuters Health Information, March 14, 2023
• Alert Two FDA Clearances Add Diabetes Technology Options The FDA has cleared Abbott Freestyle Libre versions 2 and 3 for integration with automated insulin delivery systems and Bigfoot Biomedical's Android version of its insulin dosing app.
  FDA Approvals, March 07, 2023
• Can Skin Care Aid Use of Diabetes Devices? A simple skin management program can help kids keep using critical diabetes treatment devices, researchers reported.
  Medscape Medical News, March 01, 2023
• Old Drug Verapamil May Have New Use in Type 1 Diabetes In randomized trial, the old cardiac agent slowed the destruction of insulin-producing beta cells in youth with new-onset type 1 diabetes.
  Medscape Medical News, February 27, 2023
• Skin Problems Common at Insulin Pump Infusion Sites Tissue changes from inflammatory responses could be responsible for infusion site failures.
  First Look, February 24, 2023
• Real-Time CGM Plus Insulin Pump Best for Type 1 Diabetes In youth with type 1 diabetes, real-time continuous glucose monitoring and insulin pump use were associated with more time in target glucose range versus intermittently scanned CGM and injections.
  Medscape Medical News, February 22, 2023
• Getting Started With Prescribing and Advising Patients on CGM 'We in primary care are being shepherded into this space by our patients who have seen an advertisement or talked to a friend about the benefits of CGM, and then asked us to prescribe it,' said one clinician.
  MDedge News, February 21, 2023
• Type 1 Diabetes No Longer a Disease of the Thin, Advice Needed In a nationwide survey, the prevalence of overweight/obesity was similar for people with type 1 diabetes and those without diabetes, while lifestyle advice was less commonly given than for those with type 2 diabetes.
  Medscape Medical News, February 13, 2023
• Biden to Push for Insulin Cost Caps, but Unlikely to Secure Congressional Approval US President Joe Biden will call for a nationwide cap of $35 a month on out-of-pocket insulin costs during his State of the Union Address on Tuesday, but is unlikely to get his wish as it lacks enough Congressional support.
  Reuters Health Information, February 07, 2023
• Alert FDA Okays Tidepool Loop App to Help Guide Insulin Delivery Prescription-only device works with compatible continuous glucose monitors and insulin pumps for people with type 1 diabetes aged 6 years or older.
  Medscape Medical News, January 24, 2023
• High-Deductible Health Plans Detrimental for Those With Diabetes Individuals forced to switch to high-deductible plans appear to ration care, leading to more hypo- and hyperglycemic events.
  Medscape Medical News, January 23, 2023
• Arizona Dad Seeking Answers After Son Dies in State Care "They couldn't keep him alive for two weeks, two weeks," the father told the Associated Press while on a recent furlough from jail.
  Associated Press, January 17, 2023
• Oramed Oral Insulin Fails to Meet Goal in Type 2 Diabetes Top-line results from phase 3 trial of ORMD-0801 show that the oral insulin product didn't meet the phase 3 trial's endpoints for change from baseline hemoglobin A1c at 26 weeks.
  Medscape Medical News, January 12, 2023
• Latest Steps Toward Reducing US Insulin Cost Begin in 2023 Co-pay caps for Medicare beneficiaries begin in 2023, while new federal legislation, state laws, and new insulin manufacturers all eyed as more possible solutions.
  Medscape Medical News, January 06, 2023
• IDF 2022 New Efforts to Aid Those With Diabetes in Humanitarian Crises A recently launched multisector partnership is gearing up to provide lifesaving assistance for people with diabetes in natural and man-made disaster situations.
  Medscape Medical News, December 28, 2022
• A Starting Point for Precision Medicine in Type 1 Diabetes New evidence about the epidemiology, genetics, and possible constituent causes of type 1 diabetes is offering clues to precision medicine for this disorder.
  Medscape Medical News, December 16, 2022
• Alert FDA Okays Dexcom G7 Continuous Glucose Monitoring System The new version has several advantages over the G6, including smaller size, shorter warm-up time, and a 12-hour grace period before expiring.
  Medscape Medical News, December 08, 2022
• Update Stresses New Strategies for Hypoglycemia Management The latest guideline from The Endocrine Society updates recommendations to reflect new treatment options for hypoglycemia prevention and treatment in diabetes.
  Medscape Medical News, December 08, 2022